|
AU5057101A
|
|
Treatment of pathological conditions influenced by the action of matrix metalloproteinases (mmps) using clioquinol
|
|
BR0008241A
|
|
Use of phanquinone for the preparation of a pharmaceutical composition for the treatment of memory impairment and treatment method
|
|
IL143499D0
|
|
Liposomic niflumic acid-new transdermal anti-inflammatory medicine
|
|
EP1071410A1
|
|
Ionic aqueous composition containing levomenthol
|
|
EP0908184A1
|
|
Diluted seawater based composition for the treatment of the nasal fossae
|
|
AU8124198A
|
|
Use of phanquinone for the treatment of Alzheimer's disease
|
|
US5994323A
|
|
Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof
|
|
US5980914A
|
|
Clioquinol for the treatment of Parkinson's disease
|
|
SK17999A3
|
|
The use clioquinol for the manufacture of a pharmaceutical composition for the treatment of Alzheimer's disease
|
|
AU7236094A
|
|
Thymus products and applications
|
|
AU6580494A
|
|
Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases
|
